[EN] LIM KINASE INHIBITORS, PHARMACEUTICAL COMPOSITION AND METHOD OF USE IN LIMK-MEDIATED DISEASES<br/>[FR] INHIBITEURS DE KINASE LIM, COMPOSITION PHARMACEUTIQUE ET PROCÉDÉ D'UTILISATION DANS DES MALADIES INDUITES PAR LIMK
申请人:CELLIPSE
公开号:WO2018055097A1
公开(公告)日:2018-03-29
The present invention relates to LIM Kinase inhibitors of Formula (I) and pharmaceutically acceptable salts or solvates thereof, wherein R1, R2, R3, R4, X1, X2, X3, Y1, Y2 and Z are as defined in the claims, and their use for the treatment and/or prevention of LIMK-mediated diseases.
本发明涉及式(I)的LIM激酶抑制剂及其药用盐或溶剂,其中R1、R2、R3、R4、X1、X2、X3、Y1、Y2和Z如权利要求中定义的那样,并且其用于治疗和/或预防LIMK介导的疾病。